Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Rapt Therapeutics Inc | 0 | 1,562,500 | +1,562,500 | 0 | 12,500 | 7.03% | +12,500 |
| Hinge Health Inc(HNGE) | 0 | 135,000 | +135,000 | 0 | 6,986 | 3.93% | +6,986 |
| Verastem Inc | 0 | 1,276,520 | +1,276,520 | 0 | 5,298 | 2.98% | +5,298 |
| Xenon Pharmaceuticals Inc(XENE) | 0 | 160,000 | +160,000 | 0 | 5,008 | 2.82% | +5,008 |
| CG Oncology, Inc.(CGON) | 2,221,474 | 2,221,474 | 0 | 54,404 | 57,758 | 32.47% | +3,354 |
| Ideaya Biosciences Inc(IDYA) | 0 | 144,468 | +144,468 | 0 | 3,037 | 1.71% | +3,037 |
| Kymera Therapeutics Inc(KYMR) | 146,332 | 146,332 | 0 | 4,005 | 6,386 | 3.59% | +2,381 |
| Corvus Pharmaceuticals Inc(CRVS) | 1,581,233 | 1,731,233 | +150,000 | 5,028 | 6,925 | 3.89% | +1,897 |
| Avidity Biosciences Inc | 0 | 40,000 | +40,000 | 0 | 1,136 | 0.64% | +1,136 |
| Spyre Therapeutics Inc(SYRE) | 0 | 70,000 | +70,000 | 0 | 1,048 | 0.59% | +1,048 |
| Viridian Therapeutics, Inc(VRDN) | 1,974 | 1,974 | 0 | 27 | 28 | 0.02% | +1 |
| Cullinan Therapeutics Inc(CGEM) | 634,558 | 594,025 | -40,533 | 4,804 | 4,473 | 2.51% | -331 |
| Centessa Pharmaceuticals Inc | 1,253,379 | 1,253,379 | 0 | 18,024 | 16,469 | 9.26% | -1,554 |
| Akero Therapeutics Inc | 365,000 | 244,900 | -120,100 | 14,775 | 13,068 | 7.35% | -1,707 |
| Allogene Therapeutics Inc | 3,448,275 | 2,875,357 | -572,918 | 5,034 | 3,249 | 1.83% | -1,785 |
| Casi Pharmaceuticals Inc | 1,329,383 | 787,121 | -542,262 | 2,871 | 929 | 0.52% | -1,943 |
| Structure Therapeutics Inc | 420,000 | 210,000 | -210,000 | 7,270 | 4,355 | 2.45% | -2,915 |
| Bicara Therapeutics Inc | 950,000 | 949,260 | -740 | 12,379 | 8,819 | 4.96% | -3,560 |
| Edgewise Therapeutics Inc(EWTX) | 585,000 | 585,000 | 0 | 12,870 | 7,669 | 4.31% | -5,201 |
| Alumis Inc | 4,202,670 | 4,247,670 | +45,000 | 25,804 | 12,743 | 7.16% | -13,061 |
| Rapt Therapeutics Inc | 12,500,000 | 0 | -12,500,000 | 15,250 | 0 | — | -15,250 |